Clene logo

Clene

CLNN | NASDAQ
Chart Builder DCF Calculator
$3.75
-$0.17 (-4.34%)
At close: Nov 16, 2026, 3:59 PM ET
$3.65
-$0.10 (-2.67%)
After-hours: Nov 16, 2026, 7:30 PM ET
-4.34%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
43.2
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #436/1021 (Top 43%)

Key Statistics

Market Data

Market Cap $54M
1D Range
3.55 3.84
52W Range
3.10 10.36

Valuation (TTM)

PE -1.42
PB -3.65
EV/EBITDA -2.56

Valuation (NTM)

Forward PE N/A
Forward PEG 0.11
Price Target $50.00
Loading financial charts...

Profile

Clene Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to the discovery, advancement, and market introduction of pioneering therapeutic agents utilizing clean-surfaced nan...

Sector Healthcare
Industry Biotechnology
Employees 78
IPO Date Oct 18, 2018
Website clene.com
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 4, 2026
EPS
$0.05
Beat +111.01%
REV
$56K
Miss -20.00%
Next Earnings
Mar 11, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$50.00
Upside
+1233.33%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.